Crossmark

Combined oral low-dose cyclophosphamide endocrine therapy may improve clinical response among patients with metastatic breast cancer via Tregs in TLSs

Crossref DOI link: https://doi.org/10.1038/s41598-024-64042-3

Published Online: 2024-06-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Yuze

Wang, Shuo

Lv, Shuzhen

Liu, Xiaojun

Li, Weiping

Song, Yuguang

Rong, Dongwen

Zheng, Peiming

Huang, Hongyan

Zheng, Huixia
Funding

Funding for this research was provided by:

Wu Jieping Medical Foundation (320.6750.2022-22-2)
License Information

Text and Data Mining valid from 2024-06-11

Version of Record valid from 2024-06-11
More Information

Article History

Received: 27 November 2023

Accepted: 4 June 2024

First Online: 11 June 2024

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below